Rho GTPases as therapeutic targets in Alzheimer’s disease

Por Aguilar, Byron J., Zhu, Yi, Lu, Qun
Publicado no Alzheimers Res Ther (2017)

Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase by Synthetic Musks Induces Cell Degeneration

Por Ayuk-Takem, Lambert, Amissah, Felix, Aguilar, Byron J., Lamango, Nazarius S.
Publicado em 2012

Polyisoprenylated Methylated Protein Methyl Esterase Is Both Sensitive to Curcumin and Overexpressed in Colorectal Cancer: Implications for Chemoprevention and Treatment

Por Amissah, Felix, Duverna, Randolph, Aguilar, Byron J., Poku, Rosemary A., Lamango, Nazarius S.
Publicado em 2013

Genetic Alterations of δ-Catenin/NPRAP/Neurojungin (CTNND2): Functional Implications in Complex Human Diseases

Por Lu, Qun, Aguilar, Byron J., Li, Mingchuan, Jiang, Yongguang, Chen, Yan-Hua
Publicado no Hum Genet (2016)

Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression

Por Amissah, Felix, Duverna, Randolph, Aguilar, Byron J, Poku, Rosemary A, Kiros, Gebre-Egziabher, Lamango, Nazarius S
Publicado em 2014

Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer

Por Poku, Rosemary A, Amissah, Felix, Duverna, Randolph, Aguilar, Byron J, Kiros, Gebre-Egziabher, Lamango, Nazarius S
Publicado em 2014

Characterization of 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine at androgen receptor: mechanistic support for its role in prostate cancer

Por Glass-Holmes, Mashunté, Aguilar, Byron J, Gragg, Richard D, Darling-Reed, Selina, Goodman, Carl B
Publicado no Am J Cancer Res (2014)

Polyisoprenylated Methylated Protein Methyl Esterase: a Putative Biomarker and Therapeutic Target for Pancreatic Cancer

Por Aguilar, Byron J., Nkembo, Augustine T., Duverna, Randolph, Poku, Rosemary A., Amissah, Felix, Ablordeppey, Seth Y., Lamango, Nazarius S.
Publicado em 2014